Latest Period
Q1 2026
Security Snapshot
Anixa Biosciences Inc - Common Stock (ANIX) Institutional Ownership
CUSIP: 03528H109
13F Institutional Holders and Ownership History from Q4 2018 to Q1 2026
Institutions Reporting
59
Shares (Excl. Options)
5,088,935
Price
$2.58
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- ANIX on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 5,088,935
- Total 13F value
- $13,129,890
- Portfolio coverage rank
- 0%
- Share change
- -585,996
- Value change
- -$1,889,406
- Number of holders
- 59
- Shares outstanding
- 35,258,614
- SEC-reported price per share
- $2.95
- Insider filing price
- $2.95
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- ANIX - Anixa Biosciences Inc - Common Stock is tracked under CUSIP 03528H109.
- 59 institutions reported positions in Q1 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 70 to 59 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $17,642,741 to $13,129,890.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 59 institutions filings for Q1 2026.
Security key
03528H109
Latest holder period
Q1 2026
13F holders
59
13D/G owners
2
CIK / CUSIP context first
Open Q1 2026 holders
ANIX full holder history
Anixa Biosciences Inc SEC filings
Anixa Biosciences Inc company facts
Anixa Biosciences Inc insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 03528H109:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
ANIX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| KUMAR AMIT | 16% | +8% | $16,667,362 | +$1,403,336 | 6,173,097 | +9.2% | Amit Kumar | 04 Jun 2025 |
| Catelani Michael | 7% | $10,662,205 | 2,468,103 | Michael Catelani | 05 Jan 2026 |
As of 31 Mar 2026, 59 institutional investors reported holding 5,088,935 shares of Anixa Biosciences Inc - Common Stock (ANIX). This represents 14% of the company’s total 35,258,614 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
14%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 3.7% | 1,314,982 | 0% | 0% | $3,392,654 |
| Laird Norton Wetherby Trust Company, LLC | 1.6% | 566,327 | -3.7% | 0.03% | $1,461,124 |
| UBS Group AG | 1.6% | 551,637 | +20% | 0% | $1,423,224 |
| D.A. DAVIDSON & CO. | 1.5% | 539,272 | 0% | 0.01% | $1,391,322 |
| GEODE CAPITAL MANAGEMENT, LLC | 1% | 364,731 | +3.9% | 0% | $941,440 |
| VANGUARD FIDUCIARY TRUST CO | 0.54% | 191,074 | 0% | 0% | $492,971 |
| MARSHALL WACE, LLP | 0.49% | 173,179 | +327% | 0% | $446,800 |
| BlackRock, Inc. | 0.48% | 170,103 | +3.7% | 0% | $438,865 |
| STATE STREET CORP | 0.45% | 159,040 | 0% | 0% | $410,323 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.28% | 99,468 | -61% | 0% | $256,628 |
| GSA CAPITAL PARTNERS LLP | 0.28% | 98,842 | +20% | 0.02% | $255,000 |
| LPL Financial LLC | 0.23% | 80,976 | -9.6% | 0% | $208,918 |
| NORTHERN TRUST CORP | 0.19% | 66,825 | +20% | 0% | $172,409 |
| RENAISSANCE TECHNOLOGIES LLC | 0.17% | 61,173 | +14% | 0% | $157,826 |
| CoreCap Advisors, LLC | 0.15% | 52,020 | +8.3% | 0% | $134,212 |
| Kestra Advisory Services, LLC | 0.14% | 51,000 | +96% | 0% | $131,580 |
| Bank of New York Mellon Corp | 0.13% | 47,442 | -19% | 0% | $122,401 |
| Westside Investment Management, Inc. | 0.13% | 47,000 | +6.8% | 0.02% | $121,260 |
| HighTower Advisors, LLC | 0.12% | 41,550 | +0.97% | 0% | $107,199 |
| Gemmer Asset Management LLC | 0.1% | 35,000 | 0% | 0.01% | $90,300 |
| Vontobel Holding Ltd. | 0.09% | 30,000 | 0% | $77,400 | |
| CIBC Bancorp USA Inc. | 0.08% | 26,600 | 0% | $68,628 | |
| NATIONS FINANCIAL GROUP INC, /IA/ /ADV | 0.06% | 22,500 | 0% | 0% | $58,050 |
| Corient Private Wealth LLC | 0.06% | 20,000 | -47% | 0% | $51,600 |
| Point72 Asset Management, L.P. | 0.05% | 17,276 | -44% | 0% | $44,572 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
30
Latest
Q1 2026
Rows shown
1-25 of 30
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 5,088,935 | $13,129,890 | -$1,889,406 | $2.58 | 59 |
| 2025 Q4 | 5,655,725 | $17,642,741 | +$715,226 | $3.12 | 70 |
| 2025 Q3 | 5,413,922 | $17,872,434 | +$304,259 | $3.30 | 65 |
| 2025 Q2 | 5,349,047 | $17,648,439 | -$787,212 | $3.30 | 65 |
| 2025 Q1 | 5,605,891 | $16,030,193 | -$524,324 | $2.86 | 57 |
| 2024 Q4 | 5,841,305 | $13,552,284 | +$544,864 | $2.32 | 57 |
| 2024 Q3 | 5,576,916 | $17,555,837 | +$106,953 | $3.15 | 56 |
| 2024 Q2 | 5,565,637 | $12,300,146 | +$344,963 | $2.21 | 52 |
| 2024 Q1 | 5,283,801 | $16,487,763 | +$2,705,766 | $3.12 | 58 |
| 2023 Q4 | 4,420,722 | $17,152,699 | +$1,892,994 | $3.88 | 55 |
| 2023 Q3 | 3,928,249 | $12,844,861 | +$921,910 | $3.27 | 49 |
| 2023 Q2 | 3,647,399 | $11,674,122 | -$399,198 | $3.20 | 45 |
| 2023 Q1 | 3,664,627 | $15,755,697 | +$369,660 | $4.30 | 44 |
| 2022 Q4 | 3,636,173 | $15,451,565 | +$553,415 | $4.25 | 49 |
| 2022 Q3 | 3,474,510 | $17,089,377 | +$1,187,300 | $4.92 | 41 |
| 2022 Q2 | 3,267,227 | $9,991,989 | -$78,782 | $3.06 | 42 |
| 2022 Q1 | 3,302,911 | $9,050,644 | -$407,464 | $2.74 | 37 |
| 2021 Q4 | 3,436,723 | $10,208,000 | +$525,035 | $2.97 | 39 |
| 2021 Q3 | 3,177,493 | $15,156,000 | +$1,098,635 | $4.77 | 34 |
| 2021 Q2 | 2,951,398 | $11,453,000 | -$36,263,645 | $3.88 | 29 |
| 2021 Q1 | 2,512,086 | $49,594,000 | +$41,200,982 | $4.68 | 27 |
| 2020 Q4 | 1,800,328 | $5,527,000 | +$13,066 | $3.07 | 20 |
| 2020 Q3 | 1,825,831 | $4,439,000 | +$532,898 | $2.43 | 19 |
| 2020 Q2 | 1,596,826 | $4,888,000 | +$720,757 | $3.06 | 18 |
| 2020 Q1 | 1,382,434 | $2,197,000 | +$44,107 | $1.59 | 15 |